Emami Limited EMAMILTD NIFTY_SMALLNSE
Company Overview
Emami Limited manufactures and markets personal and healthcare products in India and internationally. The company offers antiseptic cream, body lotion, prickly heat powder, petroleum jelly, soaps, aloe vera gel, and all-season cream under the BoroPlus brand; oil and cool talc products under the Navratna brand; and ayurvedic products for pain management, immunity, digestive health, and bone and joint health, as well as healthcare products comprising hair growth vitalizers, skin elixirs, organic apple cider vinegar, cough syrup, herbal tea, health juices, honey, and herb tablets under the Zandu brand. It also provides oils, conditioners, shampoos, and ayurvedic capsules under the Kesh King brand; brightening creams, and brightening and oil clear face washes for men under the Smart And Handsome brand; balms under the Mentho Plus brand; hair oils under the Emami 7 Oils in One brand; prickly heat powders under the Dermicool brand; moisturising creams and body lotions under the Creme 21 brand; deodorants, eau de toilettes, shampoos, face washes, and shower gels under the HE brand; and body sprays and perfumes, beard and shaving products, body and hair care products, face washes, gift sets, and tools and accessories under The Man Company brand. In addition, the company offers face serums, oil shots, powder face washes, and hair and pure oils under the Brillare brand; hair colors under the Emami Diamond Shine brand; talc under the Emami Golden Beauty brand; herbal fairness cream under the Emami Naturally Fair brand; cold cream under the Emami Malai Kesar Cold Cream brand; and deep moisturizing cream under the Emami Pure Glow brand. Emami Limited was founded in 1974 and is headquartered in Kolkata, India.
Why Investors Should Care
Generates a return on equity of 26.5%, reflecting efficient use of shareholder capital.
Return on capital employed stands at 28.6%.
Trades at a P/E of 22.5, below the sector median of 23.8.
Maintains a net profit margin of 20.5%.
Carries low leverage with a debt-to-equity ratio of 0.06.
Offers a dividend yield of 2.85%.
Recent Developments
- Mar 2026 Revenue of ₹3,779.51 Cr (-0.8% YoY); net profit ₹775.27 Cr.
- Trailing 12 Months Year-on-year growth — revenue -0.8%, earnings -3.9%.
- 5-Year Trend Long-term compounding — revenue CAGR 4.0%, profit CAGR 6.6%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 3.98% |
| 1 Year: | -0.78% |
Compounded Profit Growth
| 5 Years: | 6.62% |
| 1 Year: | -3.87% |
Stock Price Performance
| 1 Year: | -28.90% |
| 6 Months: | -17.06% |
| 3 Months: | -2.15% |
| 1 Month: | +4.93% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMABelow
- RSI (14)53.51 · Neutral
P/E of 22.53 is below the sector median of 23.79 — relatively cheaper than peers.
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Strong return on equity of 26.5%.
- Healthy ROCE of 28.6%.
- Excellent profit margin of 20.5%.
- Attractive dividend yield of 2.85%.
- Generates positive free cash flow.
CONS
- Trading 32.2% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Consumer Defensive).
| # | Name | CMP ₹ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | EMAMILTD Emami Limited NIFTY_SMALLNSE | 416.35 | 22.53 | ₹18,173.68 Cr | 2.85% | 28.59% | 26.51% | 3.98% | 6.62% |
| 2 | HINDUNILVR Hindustan Unilever Limited NIFTY50NSE | 2,115.10 | 33.05 | ₹4.97 L Cr | 2.05% | 22.15% | 30.86% | 2.31% | 14.12% |
| 3 | ITC ITC Limited NIFTY50NSE | 276.25 | 16.73 | ₹3.46 L Cr | 5.68% | 36.47% | 28.53% | 3.65% | 2.54% |
| 4 | NESTLEIND Nestlé India Limited NIFTY50NSE | 1,431.80 | 86.10 | ₹2.76 L Cr | 0.82% | 62.44% | 79.99% | 17.01% | 23.05% |
| 5 | DMART Avenue Supermarts Limited NSE | 3,911.80 | 85.73 | ₹2.55 L Cr | 0.00% | 16.41% | 12.14% | 17.21% | 7.69% |
| 6 | VBL Varun Beverages Limited NSE | 469.60 | 52.29 | ₹1.59 L Cr | 0.42% | 19.44% | 15.51% | 17.26% | 26.57% |
| 7 | BRITANNIA Britannia Industries Limited NSE | 5,325.50 | 50.63 | ₹1.28 L Cr | 1.69% | 61.27% | 49.61% | 5.66% | 2.95% |
| 8 | MARICO Marico Limited NIFTY_MIDNSE | 847.70 | 62.38 | ₹1.10 L Cr | 0.47% | 38.75% | 41.85% | 11.82% | 10.61% |
| 9 | GODREJCP Godrej Consumer Products Limited NSE | 1,060.60 | 58.31 | ₹1.09 L Cr | 1.84% | 21.44% | 14.71% | 4.59% | 3.02% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in INR.
| Metric | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 836.00 Cr | 826.00 Cr | 865.00 Cr | 996.00 Cr | 891.00 Cr | 906.00 Cr | - | - | 963.05 Cr | 904.09 Cr | 798.51 Cr | 1,151.81 Cr | 925.10 Cr |
| Cost of Revenue | - | - | - | - | - | - | - | - | 328.43 Cr | 276.46 Cr | 231.37 Cr | 338.26 Cr | 291.92 Cr |
| Gross Profit | - | - | - | - | - | - | - | - | 634.62 Cr | 627.63 Cr | 567.14 Cr | 813.55 Cr | 633.18 Cr |
| Operating Expenses | 636.00 Cr | 636.00 Cr | 632.00 Cr | 682.00 Cr | 682.00 Cr | 692.00 Cr | - | - | 458.71 Cr | 457.91 Cr | 433.88 Cr | 474.67 Cr | 488.73 Cr |
| Operating Income | 135.00 Cr | 144.00 Cr | 187.00 Cr | 268.00 Cr | 161.00 Cr | 170.00 Cr | - | - | 175.91 Cr | 169.72 Cr | 133.26 Cr | 338.88 Cr | 144.45 Cr |
| EBITDA | 199.00 Cr | 190.00 Cr | 233.00 Cr | 314.00 Cr | 209.00 Cr | 214.00 Cr | - | - | 240.01 Cr | 233.70 Cr | 198.08 Cr | 393.29 Cr | 209.47 Cr |
| Interest Expense | 1.00 Cr | 2.00 Cr | 2.00 Cr | 3.00 Cr | 3.00 Cr | 2.00 Cr | - | - | 2.78 Cr | 2.43 Cr | 2.63 Cr | 2.92 Cr | 3.15 Cr |
| Pretax Income | 148.00 Cr | 150.00 Cr | 196.00 Cr | 276.00 Cr | 169.00 Cr | 178.00 Cr | - | - | 193.70 Cr | 186.77 Cr | 150.18 Cr | 345.05 Cr | 164.07 Cr |
| Tax Provision | 5.92 Cr | 13.50 Cr | 15.68 Cr | 16.56 Cr | 21.97 Cr | 28.48 Cr | - | - | 31.53 Cr | 22.51 Cr | 1.83 Cr | 25.57 Cr | 20.90 Cr |
| Net Income | 142.00 Cr | 137.00 Cr | 180.00 Cr | 261.00 Cr | 147.00 Cr | 151.00 Cr | - | - | 162.17 Cr | 164.26 Cr | 148.35 Cr | 319.48 Cr | 143.18 Cr |
| Diluted EPS | 3.27 | 3.14 | 4.09 | 5.92 | 3.41 | 3.50 | - | - | 3.72 | 3.76 | 3.40 | 7.32 | 3.28 |
Profit & Loss (Annual)
Figures in INR.
| Metric | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2,076.00 Cr | 2,358.00 Cr | 2,488.00 Cr | 2,531.00 Cr | 2,695.00 Cr | 2,655.00 Cr | 2,881.00 Cr | - | 3,362.01 Cr | 3,530.27 Cr | 3,809.19 Cr | 3,779.51 Cr |
| Cost of Revenue | - | - | - | - | - | - | - | - | 1,223.77 Cr | 1,182.14 Cr | 1,194.23 Cr | 1,138.01 Cr |
| Gross Profit | - | - | - | - | - | - | - | - | 2,138.24 Cr | 2,348.13 Cr | 2,614.96 Cr | 2,641.50 Cr |
| Operating Expenses | 1,536.00 Cr | 1,670.00 Cr | 1,729.00 Cr | 1,812.00 Cr | 1,970.00 Cr | 1,970.00 Cr | 2,000.00 Cr | - | 1,522.73 Cr | 1,582.69 Cr | 1,768.06 Cr | 1,855.19 Cr |
| Operating Income | 507.00 Cr | 433.00 Cr | 450.00 Cr | 408.00 Cr | 400.00 Cr | 349.00 Cr | 513.00 Cr | - | 615.51 Cr | 765.44 Cr | 846.90 Cr | 786.31 Cr |
| EBITDA | 541.00 Cr | 688.00 Cr | 759.00 Cr | 719.00 Cr | 725.00 Cr | 685.00 Cr | 880.00 Cr | - | 924.19 Cr | 986.72 Cr | 1,081.41 Cr | 1,034.54 Cr |
| Interest Expense | 5.00 Cr | 54.00 Cr | 58.00 Cr | 34.00 Cr | 21.00 Cr | 21.00 Cr | 13.00 Cr | - | 7.39 Cr | 9.98 Cr | 9.34 Cr | 11.13 Cr |
| Pretax Income | 592.00 Cr | 423.00 Cr | 424.00 Cr | 393.00 Cr | 403.00 Cr | 374.00 Cr | 569.00 Cr | - | 669.55 Cr | 790.83 Cr | 893.86 Cr | 846.07 Cr |
| Tax Provision | 106.56 Cr | 59.22 Cr | 84.80 Cr | 86.46 Cr | 100.75 Cr | 71.06 Cr | 113.80 Cr | - | 42.14 Cr | 66.70 Cr | 91.12 Cr | 70.81 Cr |
| Net Income | 485.00 Cr | 363.00 Cr | 340.00 Cr | 306.00 Cr | 303.00 Cr | 302.00 Cr | 455.00 Cr | - | 639.57 Cr | 723.53 Cr | 806.46 Cr | 775.27 Cr |
| Diluted EPS | 10.70 | 8.00 | 7.50 | 6.77 | 6.68 | 6.67 | 10.23 | 18.88 | 14.50 | 16.55 | 18.48 | - |
Balance Sheet (Annual)
Figures in INR.
| Metric | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | 1,676.00 Cr | 2,692.00 Cr | 2,603.00 Cr | 2,798.00 Cr | 2,819.00 Cr | 2,678.00 Cr | 2,520.00 Cr | - | 3,109.85 Cr | 3,279.70 Cr | 3,533.63 Cr | 3,836.44 Cr |
| Current Assets | - | - | - | - | - | - | - | - | 1,286.81 Cr | 1,418.22 Cr | 1,733.66 Cr | 1,934.86 Cr |
| Cash & Equivalents | - | - | - | - | - | - | - | - | 46.78 Cr | 52.95 Cr | 104.63 Cr | 176.75 Cr |
| Inventory | - | - | - | - | - | - | - | - | 328.04 Cr | 323.40 Cr | 308.10 Cr | 399.57 Cr |
| Receivables | - | - | - | - | - | - | - | - | 414.60 Cr | 494.21 Cr | 451.29 Cr | 343.32 Cr |
| Total Liabilities | - | - | - | - | - | - | - | - | 797.09 Cr | 821.99 Cr | 840.27 Cr | 914.00 Cr |
| Current Liabilities | - | - | - | - | - | - | - | - | 723.89 Cr | 758.83 Cr | 779.35 Cr | 838.24 Cr |
| Long Term Debt | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Debt | 36.00 Cr | 671.00 Cr | 473.00 Cr | 326.00 Cr | 110.00 Cr | 210.00 Cr | 101.00 Cr | - | 90.51 Cr | 93.96 Cr | 89.79 Cr | 161.92 Cr |
| Total Equity | 1,231.00 Cr | 1,612.00 Cr | 1,755.00 Cr | 2,014.00 Cr | 2,076.00 Cr | 1,823.00 Cr | 1,762.00 Cr | - | 2,302.80 Cr | 2,446.59 Cr | 2,694.79 Cr | 2,923.98 Cr |
| Shares Outstanding | - | - | - | - | - | - | - | - | 44.12 Cr | 43.65 Cr | 43.65 Cr | 43.65 Cr |
Cash Flows (Annual)
Figures in INR.
| Metric | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 534.00 Cr | 562.00 Cr | 730.00 Cr | 588.00 Cr | 554.00 Cr | 531.00 Cr | 922.00 Cr | - | 748.88 Cr | 779.01 Cr | 895.88 Cr | 800.53 Cr |
| Investing Cash Flow | -237.00 Cr | -1,313.00 Cr | -306.00 Cr | -276.00 Cr | -26.00 Cr | -231.00 Cr | -224.00 Cr | - | -112.83 Cr | -205.40 Cr | -340.15 Cr | -181.14 Cr |
| Financing Cash Flow | -215.00 Cr | 502.00 Cr | -496.00 Cr | -324.00 Cr | -428.00 Cr | -405.00 Cr | -688.00 Cr | - | -607.64 Cr | -562.97 Cr | -499.61 Cr | -554.49 Cr |
| Capital Expenditure | -108.00 Cr | -132.00 Cr | -282.00 Cr | -123.00 Cr | -133.00 Cr | -148.00 Cr | -32.00 Cr | - | -40.46 Cr | -40.59 Cr | -44.57 Cr | -43.32 Cr |
| Free Cash Flow | 426.00 Cr | 430.00 Cr | 448.00 Cr | 465.00 Cr | 421.00 Cr | 383.00 Cr | 890.00 Cr | - | 708.42 Cr | 738.42 Cr | 851.31 Cr | 757.21 Cr |
| Net Change in Cash | 82.00 Cr | -249.00 Cr | -72.00 Cr | -12.00 Cr | 100.00 Cr | -106.00 Cr | 9.00 Cr | - | 28.40 Cr | 10.64 Cr | 56.12 Cr | 64.90 Cr |
Ratios (Annual)
Figures in %.
| Metric | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - | - | - | - | 63.6% | 66.5% | 68.6% | 69.9% |
| Operating Margin % | 24.4% | 18.4% | 18.1% | 16.1% | 14.8% | 13.1% | 17.8% | - | 18.3% | 21.7% | 22.2% | 20.8% |
| Net Margin % | 23.4% | 15.4% | 13.7% | 12.1% | 11.2% | 11.4% | 15.8% | - | 19.0% | 20.5% | 21.2% | 20.5% |
| ROE % | 39.4% | 22.5% | 19.4% | 15.2% | 14.6% | 16.6% | 25.8% | - | 27.8% | 29.6% | 29.9% | 26.5% |
| ROCE % | - | - | - | - | - | - | - | - | 25.8% | 30.4% | 30.7% | 26.2% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for EMAMILTD
EMAMILTD — Frequently Asked Questions
What is the current share price of Emami Limited (EMAMILTD)?
As of 2026-07-16 05:21 IST, Emami Limited (EMAMILTD) trades at ₹416.35 on NSE. Its 52-week range is ₹384.80 to ₹614.39.
What is the market capitalisation of EMAMILTD?
Emami Limited (EMAMILTD) has a market capitalisation of ₹18,173.68 Cr on NSE.
What is the P/E ratio of EMAMILTD?
EMAMILTD trades at a trailing price-to-earnings (P/E) ratio of 22.53. The industry average P/E is 23.79. Its price-to-book (P/B) ratio is 6.38.
Does EMAMILTD pay a dividend?
Emami Limited (EMAMILTD) currently offers a dividend yield of 2.85%.
What is the return on equity (ROE) of EMAMILTD?
EMAMILTD has a return on equity (ROE) of 26.51%. Its return on capital employed (ROCE) is 28.59%.
Is EMAMILTD a good stock to buy?
This page provides a data-driven analysis of Emami Limited (EMAMILTD), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.